Background ACE inhibitors attenuate the detrimental effects of angiotensin II, and improve
survival and reduce morbidity in patients with acute myocardial infarction and evidence of …

The development of angiotensin-converting enzyme inhibitors (ACE inhibitors) has been
one of the most remarkable stories in the treatment of cardiovascular diseases. Angiotensin …

Aims To evaluate the safety and efficacy of levosimendan in patients with left ventricular
failure complicating acute myocardial infarction. Methods and Results Levosimendan at …

Background—Previous studies have reported conflicting findings regarding how the
incidence of heart failure (HF) after acute myocardial infarction (AMI) has changed over time …

Objectives: We sought to evaluate the common utilization of beta-blockers and angiotensin-
converting enzyme (ACE) inhibitors or receptor blockers (RBs) in congestive heart failure …

Introduction We investigated whether the concomitant use of diuretics, non-steroidal anti-
inflammatory drugs, and angiotensin-converting enzyme inhibitors/angiotensin receptor …

BACKGROUND: No data are available on the clinical efficacy of the early administration (<
24 hours from onset of chest pain) of angiotensin-converting enzyme inhibitors in non …

OBJECTIVES To examine secular trends in the use of evidence-based therapies in a
geographically defined cohort of patients with myocardial infarction (MI) and to test the …

Objectives: To determine (i) factors which predict whether patients hospitalised with acute
myocardial infarction (AMI) receive care discordant with recommendations of clinical …

Recent research on trends in the health of the US population has highlighted impressive
gains over the past several decades. National mortality statistics have shown an increase in …